ASTMH Sets Stage for Pediatric Diarrhea, Clinical Trial Symposia
OneWorld Health will host two symposia at the 54th Annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) Dec. 11-15 in Washington, D.C..

Dr. Victoria Hale, CEO, will chair the symposium, “Rising to the Challenge: A discussion of successful strategies for conducting clinical trials in developing countries,” on Monday, Dec. 12 at 1:30pm. Read the full abstract >

The other symposium, “Enhancing ORT: Current status and future directions,” chaired by Dr. Katherine Woo will be held on Tuesday, Dec. 13 at 8:00 am.  Read the full abstract >

The Economist Honors Victoria Hale with Social and Economic Innovation Award
Victoria Hale, CEO, was among leaders honored Nov. 14 for their achievements in innovation at the Economist's 4th Annual Innovation Summit and Awards Ceremony in London. Honorees were chosen in seven categories: Bioscience, Energy and the Environment, Social and Economic, Computing and Telecommunications, Consumer Products, Business Process, and “No Boundaries.”  Dr. Hale was recognized in the Social and Economic Innovation category for her leadership of OneWorld Health, the first nonprofit pharmaceutical company in the United States that seeks to develop new and affordable medicines for the developing world. Read the press release >

Senior Program Officer to Discuss Global Health, Pharmaceutical Industry Relationship
Art Strosberg, Ph.D., will represent OneWorld Health at the 133rd Annual meeting of the American Public Health Association (APHA) on Dec. 12 in Philadelphia. As a panelist for the discussion, “Innovative Organizational Responses to Issues in the Pharmaceutical Sector,” Dr.Strosberg will describe, discuss and evaluate OneWorld Health’s response to resource shortages in global health. Read the full abstract >


Holiday Giving
Momentum continues to build behind our efforts to bring healthier lives to millions in the developing world. We cannot do this work alone. In this season of giving, please consider a tax-deductible gift to OneWorld Health. Your support enables us to grow, to seek new opportunities and to maintain our leadership as social entrepreneurs in global health. To learn about the various opportunities in which you can contribute please visit us here. Happy holidays from everyone at OneWorld Health.

Office Closure
OneWorld Health’s San Francisco office will be closed from Dec. 26- Jan. 2 and will reopen on Jan. 3, 2006.    

Esquire: Best and Brightest,  “Victoria Hale: Exec Of The Year,” December 2005
Big pharmas don't make many of the drugs that could save lives in poor countries. So Hale figured she would. Read the article >

ABC World News Tonight, “Drugs Sought for Millions with Neglected Diseases,” Nov. 5, 2005.
Parasitic illnesses afflict millions of people in poor countries, mostly in Africa and Asia. But many are known as "neglected diseases," because most drug companies don't make the medicines necessary to treat people who cannot afford to pay. Read the text > or view the video clip (35MB) >

Nature Drug Discovery, “An Audience with...Victoria G. Hale,” November 2005.
Victoria G. Hale is CEO of the Institute for OneWorld Health, a nonprofit pharmaceutical company she founded in 2000 to tackle the lack of effective, safe and affordable drugs for tropical diseases.  In addition to time spent in industry, Hale has gained valuable expertise in biopharmaceutical drug development at the FDA Center for Drug Evaluation and Research. Read the interview (PDF) >

East Bay Business Times, “Bay Area Partnership Advances Malaria R&D,” Nov. 6, 2005.
GlaxoSmithKline was the largest recipient of three Gates Foundation malaria grants totaling more than $250 million this week, getting $107 million to accelerate its malaria vaccine research. Read the article >

TB Alliance and Bayer Launch Historic Global TB Drug Trials
The Global Alliance for TB Drug Development (TB Alliance) and Bayer Healthcare AG today announced a partnership to coordinate a global clinical trial program to study the potential of an existing antibiotic, moxifloxacin, to shorten the standard 6-month treatment of tuberculosis (TB). Read the release >

Gates and Clinton Ask Americans to Give to Global Health
Microsoft Chairman Bill Gates and former President Clinton said Wednesday that Americans should take more of an interest in global health issues. Read the article >

We’re growing and looking for passionate and talented industry professionals
Please see the OneWorld Health Employment page for descriptions of our staffing needs.

We extend our thanks to the following donors for their recent gifts: In Memory Of William R. Meeker, Jr., M.D. Donors Amgen Foundation Byrna Bicknell Andrew Chu J.C. Cox L.A. Dellert Richard Dorson Stella Farrell Shawna Feldmar Emel and Thomas Hamilton Hilary and Mel Harrison Michael Helperin Ryszard Holod Brian Hughes Jerry Huller Barry Jacobs Dael Klippenstein Neil and Diane Korman Adam Kotlewski Jeff Kraft Wayne and Cheryl Lammers D. Todd Littlefield Winifred Meeker-O'Connell Maggie Morris Nitin Nagaraja Mary Norris Aran Ramos Ortega Thomas Paulus Jaya Pisupati Lois Pollock David and Vivian Pratt John Pugh Michael Vaillancourt Anthony Zackin

back to top >